Evid Invest
Who owns INBXWhat INBX owns — n/a

Who owns Inhibrx Biosciences, Inc.?

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.

Institutional ownership of INBX from SEC Form 13F filings across 173 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.

As of the 2026-09-30 reporting period, 173 institutions disclosed 14.5M shares of Inhibrx Biosciences, Inc. worth $1.38B — about 92% of shares outstanding; the largest disclosed holder is MORGAN STANLEY. Source: SEC Form 13F filings, parsed by EvidInvest.

173

13F holders

$1.38B

value, 2026 filers

92%

of shares outstanding (14.5M sh)

41

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of INBX's shares outstanding

#ManagerSharesValue% of fund% of co.Δ shares QoQ
1MORGAN STANLEY1.3M$132.2M0.0%8.4%+1.0%
2PERCEPTIVE ADVISORS LLC1.3M$129.3M2.3%8.2%-0.4%
3Sanofi1.2M$115.9M18.4%7.4%0.0%
4VIKING GLOBAL INVESTORS LP1.1M$110.9M0.3%7%-1.4%
5HighTower Advisors, LLC884,441$88.5M0.1%5.6%+1.6%
6Schonfeld Strategic Advisors LLC827,280$82.8M0.3%5.3%+18.6%
7BlackRock, Inc.821,926$82.3M0.0%5.2%-0.5%
8TIG Advisors, LLCNEW677,789$508,3420.0%4.3%new
9STATE STREET CORP565,749$56.6M0.0%3.6%-11.7%
10VANGUARD CAPITAL MANAGEMENT LLC537,262$53.8M0.0%3.4%+9.1%
11Woodline Partners LP400,892$40.1M0.1%2.6%0.0%
12Sofinnova Investments, Inc.391,621$39.2M1.7%2.5%+29.2%
13Capital Research Global Investors362,466$36.3M0.0%2.3%-0.2%
14Parkman Healthcare Partners LLC360,260$36.1M3.2%2.3%+40.2%
15PFM Health Sciences, LP320,331$32.1M3.2%2%+3.9%
16GEODE CAPITAL MANAGEMENT, LLC255,317$25.6M0.0%1.6%-0.3%
17GOLDMAN SACHS GROUP INC221,687$22.2M0.0%1.4%-34.4%
18Soleus Capital Management, L.P.NEW210,000$21.0M0.7%1.3%new
19First Turn Management, LLC171,512$17.2M2.3%1.1%+4.1%
20Trails Edge Capital Partners, LPNEW170,000$17.0M2.4%1.1%new
21CITIGROUP INC164,324$16.4M0.0%1%+117.0%
22CDC Financial, Inc.132,290$13.2M6.3%0.8%-5.6%
23FIRST TRUST ADVISORS LP126,651$12.7M0.0%0.8%-1.4%
24CAPITOLIS LIQUID GLOBAL MARKETS LLC119,200$11.9M0.1%0.8%0.0%
25VANGUARD PORTFOLIO MANAGEMENT LLC112,157$11.2M0.0%0.7%-8.5%

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.